ISMIND 2026 brings together leading experts to translate cutting-edge neuroimmunology into precise, evidence-based clinical practice.
From immune mechanisms to therapeutic decisions, each session is designed to foster critical thinking, multidisciplinary dialogue, and real-world applicability.
Session 1
Neuroimmunology Across Borders: Regional Data and Challenges
The congress opens with a strategic regional perspective. Leading representatives present epidemiological insights, clinical realities, and system-level challenges across neighboring countries.
This session sets the foundation for sustainable collaboration, shared registries, and future multicenter research initiatives.
Session 2
MS Spectrum: From Immune Heterogeneity to Progression
Multiple Sclerosis is no longer viewed as a uniform disease entity. This session examines immune heterogeneity, evolving diagnostic frameworks, and the complex mechanisms underlying progression.
A focused expert discussion will connect pathobiology with practical clinical decision-making.
Session 3
Neuroimaging: Bridging Clinical Insight and Radiological Patterns
Precise imaging interpretation is essential in differentiating MS, NMOSD, and MOGAD. Moving beyond textbook descriptions, this session integrates bedside reasoning with advanced MRI pattern recognition.
Interactive case discussions will sharpen diagnostic accuracy and therapeutic planning.
Session 4
Biomarkers: Connecting Immunology to Clinical Practice
Modern neuroimmunology depends on accurate biomarker integration. From CSF analysis and antibody profiling to OCT-based neurodegeneration assessment, this session highlights how laboratory and imaging data inform personalized care.
The emphasis is on interpretation, not just detection.
Session 5
Plenary Lecture: Autoimmune Encephalitis
Autoimmune encephalitis exemplifies the convergence of immunology and clinical neurology. This plenary lecture traces the pathway from antibody discovery to complex neuropsychiatric syndromes, addressing diagnostic refinement and contemporary treatment strategies.
Session 6
Neuro-Ophthalmic Emergencies: Critical Clinical Insights
Rapid recognition is critical in neuro-ophthalmic disorders. This session focuses on acute optic neuritis, MRI patterns that alter management, and identifying red flags that signal systemic or neurological emergencies.
Real-world cases will guide structured, evidence-based intervention.
Session 7
TBA
Session 8
Keynote Lecture: Behçet’s Disease – Systemic and Neurological Management
Behçet’s Disease remains one of the most complex multisystem inflammatory disorders in neuroimmunology. This keynote session explores systemic mechanisms, neurological phenotypes, and integrated treatment approaches, with particular emphasis on Neuro-Behçet’s management challenges.
Session 9
The Complement System: From Mechanisms to Clinical Decisions
Complement activation has become a therapeutic turning point in neuroimmune disease. This session bridges molecular insight with clinical application, examining complement-targeted strategies in MG and NMOSD while clarifying mechanistic distinctions in MOGAD.
Session 10
Infection and Immunity: Post-Infectious Neurological Complications
Infection-triggered autoimmunity represents a critical interface between systemic illness and neuroinflammation. This session analyzes pathogenic mechanisms, diagnostic differentiation, and management strategies, reinforced through case-based expert dialogue.
Session 11
TBA
Session 12
TBA
Session 13
TBA
Session 14
Women’s Health: Fertility and Pregnancy in Neuroimmunology
Managing neuroimmunological diseases during pregnancy requires precision, balance, and individualized planning. This session addresses treatment optimization, safety considerations, and postpartum strategies across MS, NMOSD, MOGAD, and immune-mediated neuromuscular disorders.